1887
Articles Open Access
Like 0
This item has no PDF Download

Abstract

Despite the global increase in tuberculosis and the worrying rise in the number of cases resistant to the two principal antituberculosis drugs, isoniazid and rifampicin, the authors of a personal view in the current issue of the Lancet Infectious Diseases think that if action is taken now this tide can be turned (1).

Loading

Article metrics loading...

/content/10.2807/esw.05.43.02043-en
2001-10-25
2017-11-20
http://instance.metastore.ingenta.com/content/10.2807/esw.05.43.02043-en
Loading
Loading full text...

Full text loading...

/deliver/fulltext/eurosurvweeklyarchive/5/43/art02043-en.htm?itemId=/content/10.2807/esw.05.43.02043-en&mimeType=html&fmt=ahah
Comment has been disabled for this content
Submit comment
Close
Comment moderation successfully completed
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error